Arrowstreet Capital’s Ultralife ULBI Stock Holding History

Arrowstreet Capital’s Portfolio ULBI Stock Details ULBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$826K	Sell	126,753 -9,708	-7%	-$60.3K	﹤0.01%	1597
2025 Q4	$781K	Sell	136,461 -82,557	-38%	-$509K	﹤0.01%	1602
2025 Q3	$1.49M	Buy	219,018 +148,542	+211%	+$1.13M	﹤0.01%	1513
2025 Q2	$633K	Buy	70,476 +58,211	+475%	+$345K	﹤0.01%	1700
2025 Q1	$66K	Sell	12,265 -6,378	-34%	-$43.4K	﹤0.01%	1774
2024 Q4	$139K	Hold	18,643	–	–	﹤0.01%	1678
2024 Q3	$169K	Sell	18,643 -37,220	-67%	-$384K	﹤0.01%	1659
2024 Q2	$593K	Sell	55,863 -26,281	-32%	-$280K	﹤0.01%	1311
2024 Q1	$724K	Hold	82,144	–	–	﹤0.01%	1382
2023 Q4	$560K	Hold	82,144	–	–	﹤0.01%	1207
2023 Q3	$802K	Buy	+82,144	New	+$658K	﹤0.01%	1033

Other funds holding ULBI

VWA

Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

THC

Truffle Hound Capital Bethesda, Maryland $386M AUM 57.88% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Arrowstreet Capital's ULBI Position: Q1 2026 in Review

Arrowstreet Capital reduced its Ultralife (ULBI) stake by 7.1% in Q1 2026, selling an estimated $60.3K and leaving 126,753 shares worth $826K. The position accounts for ﹤0.01% of the portfolio, ranked #1597.

Arrowstreet Capital first reported a position in ULBI in Q3 2023 and has held it in 11 quarters since. The position peaked at $1.49M in Q3 2025. 50 funds tracked by Wall St. Rank hold ULBI as of Q1 2026.

Arrowstreet Capital held 126,753 shares of Ultralife worth $826K as of Q1 2026.
Arrowstreet Capital sold 9,708 Ultralife shares in Q1 2026, an estimated $60.3K.
Ultralife made up ﹤0.01% of Arrowstreet Capital's portfolio in Q1 2026, its #1597 holding.
Arrowstreet Capital first reported a position in Ultralife in Q3 2023 and has held it in 11 quarters since.
Arrowstreet Capital's Ultralife position peaked at $1.49M in Q3 2025.
50 funds tracked by Wall St. Rank held Ultralife as of Q1 2026.

Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.